Auckland-based health technology startup Alimetry has received clearance from the US Food and Drug Administration for its wearable device for diagnosing gastric disorders.
Gastric Alimetry is a non-invasive test for common stomach disorders, including nausea and vomiting, gastroparesis, and functional dyspepsia.
Alongside the FDA clearance, the company announced the launch of Alimetry, Inc., its subsidiary based in Minneapolis, Minnesota, which will market and distribute the diagnostic test in the US.